Ya Meng

706 total citations
20 papers, 347 citations indexed

About

Ya Meng is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ya Meng has authored 20 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Ya Meng's work include Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (5 papers) and Pancreatic function and diabetes (4 papers). Ya Meng is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (5 papers) and Pancreatic function and diabetes (4 papers). Ya Meng collaborates with scholars based in China, Macao and United States. Ya Meng's co-authors include Guokai Chen, Weiwei Liu, Chengcheng Song, Ligong Lu, Meifen Zhang, Xiaoyu Wu, Ni Gong, Hui Liang, Vivien Ya‐Fan Wang and James A. Thomson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cell Reports.

In The Last Decade

Ya Meng

20 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ya Meng China	10	157	92	46	44	38	20	347
Linfeng Zheng China	15	131 0.8×	118 1.3×	66 1.4×	38 0.9×	32 0.8×	37	522
Noam Asna Israel	10	196 1.2×	144 1.6×	51 1.1×	63 1.4×	33 0.9×	31	557
Gemma A. Foulds United Kingdom	14	144 0.9×	74 0.8×	109 2.4×	20 0.5×	21 0.6×	28	432
Jianwei Zheng China	12	122 0.8×	112 1.2×	49 1.1×	38 0.9×	63 1.7×	47	387
Julie Rowe United States	11	135 0.9×	181 2.0×	47 1.0×	12 0.3×	46 1.2×	30	495
Emily Gao United States	14	135 0.9×	36 0.4×	24 0.5×	45 1.0×	66 1.7×	25	453
Felicia Rustandy Singapore	3	222 1.4×	63 0.7×	27 0.6×	42 1.0×	23 0.6×	4	383
Yi Fang China	11	80 0.5×	70 0.8×	58 1.3×	17 0.4×	44 1.2×	44	347
Patrick B. Thomas Australia	13	188 1.2×	85 0.9×	39 0.8×	43 1.0×	21 0.6×	29	378

Countries citing papers authored by Ya Meng

Since Specialization

Citations

This map shows the geographic impact of Ya Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya Meng more than expected).

Fields of papers citing papers by Ya Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya Meng. The network helps show where Ya Meng may publish in the future.

Co-authorship network of co-authors of Ya Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Ya Meng. A scholar is included among the top collaborators of Ya Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya Meng. Ya Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Ling, Yuejuan Cheng, Wenfei Zhu, et al.. (2024). Huangqi Jianzhong decoction improves gastric intestinal metaplasia in rats by regulating the gut‒thyroid axis. Phytomedicine. 135. 156174–156174. 4 indexed citations

Qin, Mingming, et al.. (2024). CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy. Journal of Translational Medicine. 22(1). 516–516. 8 indexed citations

Rugo, Hope S., Sara M. Tolaney, Aditya Bardia, et al.. (2024). Pooled safety analysis of sacituzumab govitecan (SG) in multiple solid tumor types.. Journal of Clinical Oncology. 42(16_suppl). 3029–3029. 4 indexed citations

Zhang, Jian, Yan Du, Ya Meng, et al.. (2023). 385MO A multicenter, open-label, dose escalation and expansion study of DP303c in patients with HER2-positive pre-treated advanced solid tumors. Annals of Oncology. 34. S340–S340. 2 indexed citations

Ye, Yi, Xia Xiao, Lingling Hu, et al.. (2023). Definitive Endodermal Cells Supply an in vitro Source of Mesenchymal Stem/Stromal Cells. Communications Biology. 6(1). 476–476. 7 indexed citations

Gong, Ni, Ya Meng, Qianqian Du, et al.. (2022). Obstacles to access to community care in urban senior-only households: a qualitative study. BMC Geriatrics. 22(1). 122–122. 24 indexed citations

Zhang, Xueying, Wenxia Zhang, Qianqian Du, et al.. (2021). Risk factors for prolonged intensive care unit stays in patients after cardiac surgery with cardiopulmonary bypass: A retrospective observational study. International Journal of Nursing Sciences. 8(4). 388–393. 6 indexed citations

Wu, Xiaoyu, Ni Gong, Ya Meng, et al.. (2021). Risk perception trajectory of elderly chronic disease patients in the community under COVID-19: A qualitative research. Geriatric Nursing. 42(6). 1303–1308. 5 indexed citations

Meng, Ya, et al.. (2021). Lysophosphatidic acid shifts metabolic and transcriptional landscapes to induce a distinct cellular state in human pluripotent stem cells. Cell Reports. 37(9). 110063–110063. 15 indexed citations

10.

Liu, Jie, Shuo Yang, Bihui Cao, et al.. (2021). Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes. Journal of Hematology & Oncology. 14(1). 21–21. 75 indexed citations

11.

Zhang, Yiheng, et al.. (2021). Factors associated with returning to work and work ability of colorectal cancer survivors. Supportive Care in Cancer. 30(3). 2349–2357. 9 indexed citations

12.

Xu, Jiaqi, et al.. (2021). Nicotinamide promotes pancreatic differentiation through the dual inhibition of CK1 and ROCK kinases in human embryonic stem cells. Stem Cell Research & Therapy. 12(1). 362–362. 12 indexed citations

13.

Meng, Ya, Chengcheng Song, Xiaohong Li, et al.. (2021). Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells. Cell Death and Disease. 12(12). 1119–1119. 4 indexed citations

14.

Du, Qianqian, Jingyu Chen, Ya Meng, et al.. (2021). Factors Associated With Colorectal Cancer Screening Among First-Degree Relatives of Patients With Colorectal Cancer in China. Cancer Nursing. 45(2). E447–E453. 4 indexed citations

15.

Gong, Ni, Qianqian Du, Yiheng Zhang, et al.. (2020). Treatment decision-making for older adults with cancer: A qualitative study. Nursing Ethics. 28(2). 242–252. 22 indexed citations

16.

Zhong, Hui, Xiaoyan Wang, Wenjun Ni, et al.. (2020). Stagewise keratinocyte differentiation from human embryonic stem cells by defined signal transduction modulators. International Journal of Biological Sciences. 16(8). 1450–1462. 14 indexed citations

17.

Xu, Lin, et al.. (2020). <p>Effect of RSK4 on Biological Characteristics of Gastric Cancer</p>. Cancer Management and Research. Volume 12. 611–619. 8 indexed citations

18.

Song, Chengcheng, Ya Meng, Yiqi Yang, et al.. (2019). Elevated Exogenous Pyruvate Potentiates Mesodermal Differentiation through Metabolic Modulation and AMPK/mTOR Pathway in Human Embryonic Stem Cells. Stem Cell Reports. 13(2). 338–351. 41 indexed citations

19.

Yang, Yang, Ya Meng, Nana Ai, et al.. (2019). Endogenous IGF Signaling Directs Heterogeneous Mesoderm Differentiation in Human Embryonic Stem Cells. Cell Reports. 29(11). 3374–3384.e5. 19 indexed citations

20.

Meng, Ya, Xiaoxiao Zhou, Chengcheng Song, et al.. (2018). Nicotinamide Promotes Cell Survival and Differentiation as Kinase Inhibitor in Human Pluripotent Stem Cells. Stem Cell Reports. 11(6). 1347–1356. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact